Alterity Therapeutics Lim... (ATHE)
NASDAQ: ATHE
· Real-Time Price · USD
4.21
0.02 (0.48%)
At close: Oct 03, 2025, 3:59 PM
4.24
0.83%
After-hours: Oct 03, 2025, 04:10 PM EDT
Alterity Therapeutics Balance Sheet Statement
Financials in AUD. Fiscal
year is
July - June.
| Fiscal Year | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 | Dec 31, 2020 |
Cash & Equivalents | 33.16M | 4.54M | 12.64M | 12.32M | 15.77M | 25.34M | 34.81M | 37M | 28.12M | 35.04M |
Short-Term Investments | 7.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | -268.86K | -174.64K | -218.52K | -68.31K | -96.81K | -38.23K |
Receivables | 3.94M | 5.63M | 4.04M | 5.81M | 8.67M | 7.08M | 4.73M | 6.26M | 4.28M | 1.98M |
Inventory | n/a | n/a | n/a | n/a | 2.57M | n/a | 1.6M | n/a | 1.09M | n/a |
Other Current Assets | 41.81K | 269.41K | 40.67K | 3.87M | 39.76K | 792.68K | 10.23K | 1.6M | 9.36K | 348.69K |
Total Current Assets | 45.87M | 10.43M | 19.04M | 21.99M | 27.05M | 33.21M | 41.14M | 44.86M | 33.49M | 37.37M |
Property-Plant & Equipment | 155.17K | 115.75K | 186.88K | 199.48K | 268.86K | 174.64K | 218.52K | 68.31K | 96.81K | 38.23K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 155.17K | 115.75K | 186.88K | 199.48K | 268.86K | 174.64K | 218.52K | 68.31K | 96.81K | 38.23K |
Total Assets | 46.03M | 10.55M | 19.22M | 22.19M | 27.32M | 33.38M | 41.36M | 44.93M | 33.59M | 37.41M |
Account Payables | 538.28K | 2.05M | 581.14K | 3.63M | 1.72M | 4.44M | 2.64M | 3.13M | 1.45M | 2.33M |
Deferred Revenue | n/a | n/a | n/a | n/a | -107.18K | n/a | 3.1M | -15.17K | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 876.05K | 146.00 | 4.12M | 27.13K | 61.84K | 87.6K | 84.55K | n/a | 33.84K | 717.12K |
Total Current Liabilities | 3.53M | 2.72M | 5.37M | 4.49M | 4.38M | 5.23M | 5.82M | 3.76M | 3.07M | 3.04M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 19.5K | 47.35K | 13.75K | 12.91K | 9.77K | 8.09K |
Total Long-Term Liabilities | 88.55K | 43.12K | 51.91K | 76.5K | 122.71K | 47.35K | 73.61K | 39.63K | 47.67K | 8.09K |
Total Liabilities | 3.62M | 2.76M | 5.43M | 4.57M | 4.5M | 5.28M | 5.89M | 3.8M | 3.12M | 3.05M |
Total Debt | 155.46K | 105.83K | 159.04K | 255.6K | 210.38K | 29.33K | 117.49K | 41.89K | 65.65K | n/a |
Book Value | 42.4M | 7.79M | 13.8M | 17.62M | 22.81M | 28.1M | 35.47M | 41.13M | 30.47M | 34.36M |
Book Value Per Share | 3.40 | 0.91 | 1.31 | 4.22 | 5.61 | 6.99 | 8.84 | 10.26 | 8.77 | 15.58 |
Common Stock | 262.95M | 223.52M | 223.15M | 214.98M | 213.97M | 213.83M | 213.79M | 213.81M | 197.45M | 194.89M |
Retained Earnings | -225.89M | -221.01M | -214.16M | -201.63M | -195.13M | -189.38M | -181.88M | -176.31M | -169.73M | -162.98M |
Comprehensive Income | n/a | 5.27M | 4.81M | 4.28M | 3.97M | 3.66M | 3.57M | 3.63M | 2.75M | 2.44M |
Shareholders Equity | 42.4M | 7.79M | 13.8M | 17.62M | 22.81M | 28.1M | 35.47M | 41.13M | 30.47M | 34.36M |
Total Investments | 7.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |